IEX Stock Recent News

Idex (IEX) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.06 per share a year ago.

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended June 30, 2025. “IDEX teams once again delivered strong execution in the second quarter in what continues to be a challenging operating environment,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President. “Order trends in our rapid-turn businesses downshifted slightly exiting the second quarter although current levels suggest a steady sequ.

IEX is likely to extend its earnings beat streak as strong HST and FSDP demand offsets FMT softness and rising costs.

Idex (IEX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Idex (IEX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE:IEX) announced today that it will release its second quarter 2025 financial results on Wednesday, July 30, 2025, prior to market open. An investor conference call and webcast will take place at 8:00 a.m. (CT) that same day with Chief Executive Officer and President Eric Ashleman and Vice President Corporate Development and Interim Chief Financial Officer Akhil Mahendra. The event and associated earnings presentation will be available via.

Asking 'why' repeatedly is crucial for investors to understand the root causes of macroeconomic shifts and avoid being blind sided by market disruptions. The current U.S. policy shift favors growth over inflation control, increasing risks of higher inflation and short-term debt refinancing challenges. Given these risks, I recommend increasing exposure to real assets, REITs, and cyclical value stocks for inflation protection and potential outperformance.

IDEX delivers steady cash flow and high margins from niche industrial markets, supported by a diversified portfolio and mission-critical products. Financial health is robust, with strong free cash flow, moderate leverage, and consistent shareholder returns via dividends and buybacks. The growth outlook is modest (1–3% organic sales, $8.10–8.45 EPS), but the valuation is fair given stability, efficiency, and resilience to market shocks.

My Top 15 High-Growth Dividend Stocks outperformed SPY and VIG in June, gaining 6.15% versus SPY's 5.14% and VIG's 3.41%. The list's year-to-date return is 12.59%, beating SPY every month in 2025, though still a bit short of my 12% annualized target. The July 2025 Top 15 stocks offer a 1.38% average dividend yield with an 18.78% 5-year dividend growth rate and are 23% undervalued.

Reference is made to the stock exchange notice from IDEX Biometrics ASA on 23 June 2025 regarding the issuance of shares. IDEX Biometrics ASA informs of a primary insider transaction as listed in the attached notification.